Constitutive STAT3 activation has been found in multiple types of tumors, including melanoma, prostate cancer, head and neck squamous cell carcinoma [20], [21], and inactivation of STAT3 has been found to inhibit a variety of malignancies [19], [22]. This evidence concerns the gene STAT3 and head and neck squamous cell carcinoma.